Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.000
0.00 (0.00%)
At close: Jun 16, 2025, 4:00 PM
1.990
-0.010 (-0.50%)
After-hours: Jun 16, 2025, 7:54 PM EDT
Inovio Pharmaceuticals Market Cap
Inovio Pharmaceuticals has a market cap or net worth of $73.35 million as of June 16, 2025. Its market cap has decreased by -71.80% in one year.
Market Cap
73.35M
Enterprise Value
16.26M
1-Year Change
-71.80%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since March 31, 1999, Inovio Pharmaceuticals's market cap has increased from $71.80M to $73.35M, an increase of 2.16%. That is a compound annual growth rate of 0.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 73.30M | 53.35% |
| Dec 31, 2024 | 47.80M | -65.66% |
| Dec 29, 2023 | 139.20M | -64.23% |
| Dec 30, 2022 | 389.20M | -62.93% |
| Dec 31, 2021 | 1.05B | -29.98% |
| Dec 31, 2020 | 1.50B | 354.33% |
| Dec 31, 2019 | 330.00M | -13.48% |
| Dec 31, 2018 | 381.40M | 2.28% |
| Dec 29, 2017 | 372.90M | -27.45% |
| Dec 30, 2016 | 514.00M | 5.96% |
| Dec 31, 2015 | 485.10M | -12.78% |
| Dec 31, 2014 | 556.20M | -7.96% |
| Dec 31, 2013 | 604.30M | 768.25% |
| Dec 31, 2012 | 69.60M | 27.71% |
| Dec 30, 2011 | 54.50M | -54.51% |
| Dec 31, 2010 | 119.80M | 2.92% |
| Dec 31, 2009 | 116.40M | 408.30% |
| Dec 31, 2008 | 22.90M | -43.18% |
| Dec 31, 2007 | 40.30M | -65.53% |
| Dec 29, 2006 | 116.90M | 163.88% |
| Dec 30, 2005 | 44.30M | -38.64% |
| Dec 31, 2004 | 72.20M | -1.77% |
| Dec 31, 2003 | 73.50M | 440.44% |
| Dec 31, 2002 | 13.60M | -37.04% |
| Dec 31, 2001 | 21.60M | -15.63% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |